 Cresco Labs Inc. CRLBF, 2.37 CL, 0.90 said Tuesday its third-quarter loss narrowed to 3.25 million from 263.5 million in the year-ago period, which included a 291 million impairment loss. The Chicago-based cannabis company did not provide a loss per share figure. 